CTX and its desacetyl derivative (des-CTX): interaction with some representative beta-lactamases and their related pattern of resistance to newer selected clinical isolates

Drugs Exp Clin Res. 1990;16(11):549-56.

Abstract

In this study the kinetic features of cefotaxime (CTX) and desacetyl-cefotaxime towards several representative beta-lactamases were investigated. Desacetyl-CTX was more stable to hydrolysis in comparison with cefotaxime for all the investigated enzymes. However, a cephalosporinase produced in Acinetobacter was progressively inactivated by both CTX and des-CTX. After prolonged incubation, dialysis partially restored the enzyme activity. Finally, both compounds were tested against selected resistant strains. It is concluded that des-CTX, because of either poor hydrolysis or prolonged half-life in body fluids, could contribute in vivo to the good antimicrobial properties of cefotaxime.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Cefotaxime / analogs & derivatives*
  • Cefotaxime / pharmacology*
  • Drug Resistance, Microbial*
  • Enterobacteriaceae / drug effects
  • Kinetics
  • Microbial Sensitivity Tests
  • beta-Lactamase Inhibitors*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamase Inhibitors
  • desacetylcefotaxime
  • Cefotaxime